Evidence supporting the use of: Carotenoids
For the body system: Prostate

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Table of Contents

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Carotenoids, particularly lycopene (a type of carotenoid found abundantly in tomatoes), have been studied for their potential role in supporting prostate health. Several epidemiological studies suggest that higher dietary intake of lycopene is associated with a reduced risk of prostate cancer. For example, a large meta-analysis published in the journal Cancer Epidemiology, Biomarkers & Prevention (2015) reported an inverse association between lycopene intake and prostate cancer risk, especially for advanced prostate cancer. The proposed mechanisms include antioxidant activity, modulation of cell growth, and influence on androgen signaling pathways, all of which are relevant to prostate tissue health.

However, randomized controlled trials (RCTs) have yielded mixed results. Some RCTs have shown that lycopene supplementation can lower prostate-specific antigen (PSA) levels or slow the progression of prostate lesions, while others found no significant effect. No major health authority currently endorses carotenoids as a proven strategy for prostate disease prevention or treatment, but ongoing research continues to explore their potential. Other carotenoids, such as beta-carotene, have not shown clear benefits for prostate health and, in some cases, may pose risks in certain populations (e.g., smokers).

In summary, there is moderate scientific evidence—largely from observational studies—supporting the use of carotenoids, particularly lycopene, in supporting prostate health. While promising, more robust clinical trial data are needed for definitive recommendations.

More about carotenoids
More about Prostate

Products containing carotenoids

We currently have no products on Vitabase that contain this ingredient.